Heal Venture Lab is a venture builder community focused on bringing capital and outcome-driven medical innovations to Asia Pacific to improve on healthcare access and affordability. The company is creating a regional accelerator with focus on biomed product and service innovations on critical unmet epidemiology while creating a hub and spoke network for Asia with Singapore as the central hub.
Managing Partner
Managing Partner
(Board Director)
Venture Partner
Venture Partner
Venture Partner
High-risk early-stage platforms and “Drug Factories.”
→ Option Value & Convexity
→ 10x – 30x ROI Target
→ Power Law Fund Returner
Clinical value inflections (Phase 1b to Phase 2 PoC).
→ De-risking Inflection
→ 3x – 7x ROI Target
→ Primary M&A Exit Zone
Late-stage Medtech, Diagnostics, or Digital Health.
→ Capital Preservation
→ ~2x ROI Target
→ DPI & Velocity Focus
Therapeutic areas and unmet medical needs
Affordability and accessibility
Outcome-driven, scalable, and sustainable ventures
Sector & Stage
Advanced medtech, biotech, and digital health
Early to growth stage
(pre-A to Series B)
Core Capabilities
Regulatory submission and reimbursement strategy
Clinical development and trial support
Manufacturing, distribution, and commercial partnerships
Market validation, unmet need mapping, regulatory planning
Study design, CRO/CRO access, reimbursement strategy
Fundraising, investor syndication, strategic exits
Study design, CRO/CRO access, reimbursement strategy
Partner introductions, manufacturing localization
